Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Non-Current Liabilities (2019 - 2021)

Historic Other Non-Current Liabilities for IDEAYA Biosciences (IDYA) over the last 3 years, with Q3 2021 value amounting to $6000.0.

  • IDEAYA Biosciences' Other Non-Current Liabilities fell 5000.0% to $6000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $6000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $12000.0 for FY2020, which is 6470.59% down from last year.
  • According to the latest figures from Q3 2021, IDEAYA Biosciences' Other Non-Current Liabilities is $6000.0, which was down 5000.0% from $6000.0 recorded in Q2 2021.
  • Over the past 5 years, IDEAYA Biosciences' Other Non-Current Liabilities peaked at $60000.0 during Q2 2019, and registered a low of $6000.0 during Q1 2021.
  • In the last 3 years, IDEAYA Biosciences' Other Non-Current Liabilities had a median value of $14000.0 in 2020 and averaged $22500.0.
  • Per our database at Business Quant, IDEAYA Biosciences' Other Non-Current Liabilities crashed by 7692.31% in 2020 and then plummeted by 5000.0% in 2021.
  • Quarter analysis of 3 years shows IDEAYA Biosciences' Other Non-Current Liabilities stood at $34000.0 in 2019, then plummeted by 64.71% to $12000.0 in 2020, then tumbled by 50.0% to $6000.0 in 2021.
  • Its Other Non-Current Liabilities was $6000.0 in Q3 2021, compared to $6000.0 in Q2 2021 and $6000.0 in Q1 2021.